摘要
目的分析靶点注射经皮椎体后凸成形术(靶点注射PKP)对胸腰椎骨松性压缩骨折(OVCF)治疗效果及影像学特点。方法将济南市第三人民医院于2019年1月至2020年1月收治的胸腰椎骨松性压缩骨折患者206例作为本次研究对象,分为观察组和对照组,对比分析两组患者临床疗效、手术时间、骨水泥注入量、复位率、手术前后VAS评分、椎体高度。结果相较于对照组患者,观察组患者临床疗效明显更高,差异有统计学意义(P<0.05);两组患者手术时间对比,差异无统计学意义(P>0.05),而与对照组患者相比较,观察组患者骨水泥注入量明显更少,复位率明显更高,差异有统计学意义(P<0.05);两组患者手术前VAS评分以及椎体高度对比,差异无统计学意义(P>0.05),治疗后,与对照组患者相比较,观察组患者VAS评分明显更低,椎体高度明显更高,差异有统计学意义(P<0.05)。结论在胸腰椎骨松性压缩骨折患者的治疗中对患者采用靶点注射经皮椎体后凸成形术治疗将更有利于提高患者临床疗效以及椎体高度,相较于常规手术治疗复位率更高,患者术后疼痛更小,值得临床广泛应用。
Objective To analyze the therapeutic effect and imaging characteristics of percutaneous kyphoplasty(PKP)with target injection in the treatment of thoracolumbar osteoporotic compression fractures(OVCF).Methods From January 2019 to January 2020,206 patients with thoracolumbar vertebral osteoporotic compression fractures in Jinan Third People’s Hospital were divided into observation group and control group.The clinical efficacy,operation time,bone cement injection,reduction rate,VAS score before and after operation,vertebral height of the two groups were compared and analyzed.Results Compared with the control group,the clinical efficacy of the observation group was significantly higher(P<0.05).There was no significant difference in operation time between the two groups(P>0.05),but compared with the control group,the amount of bone cement injection in the observation group was significantly less,and the reduction rate was significantly higher(P<0.05).There was no significant difference in VAS score and vertebral height between the two groups before operation(P>0.05).After treatment,compared with the control group,the VAS score of the observation group was significantly lower and the vertebral height was significantly higher(P<0.05).Conclusion In the treatment of patients with thoracolumbar osteoporotic compression fractures,percutaneous kyphoplasty with target injection is more conducive to improve the clinical efficacy and vertebral height of patients.Compared with conventional surgery,the reduction rate is higher and the postoperative pain is smaller,which is worthy of wide clinical application.
作者
刘维财
LIU Wei-cai(Jinan Third People’s Hospital,Jinan,Shandong 250132)
出处
《智慧健康》
2021年第23期57-59,共3页
Smart Healthcare
